CSI Market
Sign In | Register

Nanoviricides inc (NNVC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NNVC Annual Cash Flow →
This page allows investors to follow Nanoviricides inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
9 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-6.00
Depreciation & amortization0.39
Amortization of Other Assets0.01
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.28
Income (Loss) from Equity Method Investments0.00
Adjustment of Warrants Granted for Services0.00
Preferred Shares Issued For License-
Preferred Shares Issued As Compensation0.04
Shares And Warrants Issued For Services-
Amortization Of Deferred Compensation-
Change In Fair Value Of Derivative Liability-
Non Cash Interest On Convertible Debentures-
Common Stock Issued For Services Rendered-
Amortization Of Deferred Charges-
Common Stock Issued Upon Conversion Of Convertible Debentures-
Debt Discounts Related To Beneficial Conversion Feature Of Convertible Debt-
Stock Warrants Issued In Connection With Private Placement-
Gains Losses On Extinguishment Of Series C Debenture-
Increase Decrease In Accounts Payable Non Related Parties-0.32
Gain Loss On Warrant Settlement-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable, Related Parties0.08
Increase (Decrease) in Other Accrued Liabilities0.00
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense-0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-5.57
Investing Activities
Capital Expenditures-0.08
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments for Advance to Affiliate0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.91
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Exercise Of Stock Warrants Attached Convertible Debentures-
Stock Subscription Received-
Proceeds From Issuance Of Common Stock And Warrants-
Proceeds From Loans Payable-
Payment Of Loans Payable-
Net Proceeds From Issuance Of Common Stock And Common Stock Warrants5.40
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.31
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-5.66
Total Cash Flow1.65
4 historic quarters locked

Sign in to unlock the full Nanoviricides inc cash flow history.

Sign In Create Free Account

About Nanoviricides Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-061499

Figures are derived from filed reports and may be restated. Historical data is subject to revision.